Literature DB >> 20709548

Application of a novel in silico high-throughput screen to identify selective inhibitors for protein-protein interactions.

Catherine Joce1, Joshua A Stahl, Mitesh Shridhar, Mark R Hutchinson, Linda R Watkins, Peter O Fedichev, Hang Yin.   

Abstract

Increasing numbers of target protein structures available for computational studies makes the structure-based screening paradigm more attractive for initial hit indentification. We have developed a novel in silico screening methodology incorporating Molecular Mechanics (MM)/implicit solvent methods to evaluate binding free energies and applied this technology to the identification of inhibitors of the TLR4/MD-2 interaction. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709548      PMCID: PMC2930491          DOI: 10.1016/j.bmcl.2010.07.103

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  31 in total

1.  Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation.

Authors:  A Poltorak; P Ricciardi-Castagnoli; S Citterio; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  Polarization of chemoattractant receptor signaling during neutrophil chemotaxis.

Authors:  G Servant; O D Weiner; P Herzmark; T Balla; J W Sedat; H R Bourne
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

Review 3.  The Toll receptor family and microbial recognition.

Authors:  R Medzhitov; C Janeway
Journal:  Trends Microbiol       Date:  2000-10       Impact factor: 17.079

Review 4.  Inhibition of protein-protein interactions using designed molecules.

Authors:  Andrew J Wilson
Journal:  Chem Soc Rev       Date:  2009-07-27       Impact factor: 54.564

5.  The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.

Authors:  Beom Seok Park; Dong Hyun Song; Ho Min Kim; Byong-Seok Choi; Hayyoung Lee; Jie-Oh Lee
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

6.  Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).

Authors:  Mark R Hutchinson; Yingning Zhang; Kimberley Brown; Benjamen D Coats; Mitesh Shridhar; Paige W Sholar; Sonica J Patel; Nicole Y Crysdale; Jacqueline A Harrison; Steven F Maier; Kenner C Rice; Linda R Watkins
Journal:  Eur J Neurosci       Date:  2008-07       Impact factor: 3.386

7.  Ca2+ influx is an essential component of the positive-feedback loop that maintains leading-edge structure and activity in macrophages.

Authors:  John H Evans; Joseph J Falke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

8.  Evidence that opioids may have toll-like receptor 4 and MD-2 effects.

Authors:  Mark R Hutchinson; Yingning Zhang; Mitesh Shridhar; John H Evans; Madison M Buchanan; Tina X Zhao; Peter F Slivka; Benjamen D Coats; Niloofar Rezvani; Julie Wieseler; Travis S Hughes; Kyle E Landgraf; Stefanie Chan; Stephanie Fong; Simon Phipps; Joseph J Falke; Leslie A Leinwand; Steven F Maier; Hang Yin; Kenner C Rice; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2009-08-11       Impact factor: 7.217

Review 9.  Small-molecule inhibitors of protein-protein interactions.

Authors:  Thorsten Berg
Journal:  Curr Opin Drug Discov Devel       Date:  2008-09

Review 10.  Structure and function of Toll receptors and their ligands.

Authors:  Nicholas J Gay; Monique Gangloff
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

View more
  13 in total

Review 1.  Targeting protein-protein interfaces using macrocyclic peptides.

Authors:  Meng Gao; Kui Cheng; Hang Yin
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

2.  Morphine activates neuroinflammation in a manner parallel to endotoxin.

Authors:  Xiaohui Wang; Lisa C Loram; Khara Ramos; Armando J de Jesus; Jacob Thomas; Kui Cheng; Anireddy Reddy; Andrew A Somogyi; Mark R Hutchinson; Linda R Watkins; Hang Yin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

3.  Small-molecule inhibitors of the TLR3/dsRNA complex.

Authors:  Kui Cheng; Xiaohui Wang; Hang Yin
Journal:  J Am Chem Soc       Date:  2011-02-28       Impact factor: 15.419

Review 4.  Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation.

Authors:  Jing Li; Adam Csakai; Jialin Jin; Fengchun Zhang; Hang Yin
Journal:  ChemMedChem       Date:  2015-07-01       Impact factor: 3.466

5.  Development of β-amino alcohol derivatives that inhibit Toll-like receptor 4 mediated inflammatory response as potential antiseptics.

Authors:  Sherry A Chavez; Alexander J Martinko; Corinna Lau; Michael N Pham; Kui Cheng; Douglas E Bevan; Tom E Mollnes; Hang Yin
Journal:  J Med Chem       Date:  2011-06-02       Impact factor: 7.446

6.  Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo.

Authors:  Peter Fedichev; Roman Timakhov; Tim Pyrkov; Evgeny Getmantsev; Andrey Vinnik
Journal:  PLoS Curr       Date:  2011-08-07

Review 7.  The TB Structural Genomics Consortium: a decade of progress.

Authors:  Nicholas Chim; Jeff E Habel; Jodie M Johnston; Inna Krieger; Linda Miallau; Ramasamy Sankaranarayanan; Robert P Morse; John Bruning; Stephanie Swanson; Haelee Kim; Chang-Yub Kim; Hongye Li; Esther M Bulloch; Richard J Payne; Alexandra Manos-Turvey; Li-Wei Hung; Edward N Baker; J Shaun Lott; Michael N G James; Thomas C Terwilliger; David S Eisenberg; James C Sacchettini; Celia W Goulding
Journal:  Tuberculosis (Edinb)       Date:  2011-01-17       Impact factor: 3.131

Review 8.  Targeting Toll-like receptors with small molecule agents.

Authors:  Xiaohui Wang; Christina Smith; Hang Yin
Journal:  Chem Soc Rev       Date:  2013-06-21       Impact factor: 54.564

9.  Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4.

Authors:  X Wang; Y Zhang; Y Peng; M R Hutchinson; K C Rice; H Yin; L R Watkins
Journal:  Br J Pharmacol       Date:  2016-02-04       Impact factor: 8.739

10.  Discovery of a small-molecule antiviral targeting the HIV-1 matrix protein.

Authors:  Isaac Zentner; Luz-Jeannette Sierra; Lina Maciunas; Andrei Vinnik; Peter Fedichev; Marie K Mankowski; Roger G Ptak; Julio Martín-García; Simon Cocklin
Journal:  Bioorg Med Chem Lett       Date:  2012-11-29       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.